Homeopathic and integrative treatment for feline hyperthyroidism – four cases (2006–2010)

/

Sara Fox Chapman Corresponding Author Contact Information, E-mail The Corresponding Author

Purchase

The Animal Medical Center of Watkins Park, PO Box 426, Cheltenham, MD 20623, USA

Received 7 February 2011; revised 13 May 2011; Accepted 24 May 2011. Available online 28 September 2011.

Hyperthyroidism is a frequent veterinary problem, particularly in elderly cats. Homeopathic treatment and other integrative modalities were provided for four hyperthyroid cats whose owners did not want conventional treatment. Symptomatic homeopathic treatment with Thyroidinum was helpful in one cat. All cats were prescribed an appropriate individualized homeopathic remedy. All four cats showed resolution of clinical signs; three attained normal thyroid hormone levels. Three cats later received acupuncture and/or herbal medicines; two cats later received symptomatic homeopathic remedies. Two cats are thriving after over 3.5 and 4.25 years of treatment; two were euthanized for unrelated problems after 3 and 4 years of treatment. Homeopathic and complementary therapies avoid the potential side effects of methimazole and surgical thyroidectomy, they are less costly than radioactive iodine treatment, and they provide an option for clients who decline conventional therapies.

Keywords: Hyperthyroidism; Feline; Thyroidinum; Constitutional; Individualized; Veterinary; Homeopathy

Ultra High Dilution of triiodothyronine modifies cellular apoptosis in Rana catesbeiana tadpole tail in vitro

/

J.R.P. Guedes1, Corresponding Author Contact Information, E-mail The Corresponding Author, S. Carrasco2, C.M. Ferreira3, L.V. Bonamin4, 5, W. Souza1, C. Goldenstein-Schainberg2, E.R. Parra1, V.L. Capelozzi1

 

Received 14 June 2010; revised 27 April 2011; Accepted 6 May 2011. Available online 28 September 2011.

Background

Ultra High Dilutions (UHD) are diluted beyond the Avogadro limit with dynamization (dilution with succussion). The process of anuran amphibian metamorphosis is controlled by thyroid hormones, including the resorption of the tadpole tail.

Methods

A randomized and blinded study was performed to investigate the influence of triiodothyronine (T3) 5 · 10−24 M (10cH) on apoptosis induced by T3 100 nM in Rana catesbeiana tadpoles’ tail tips, in vitro. Explants were randomized to three groups: control: no T3 in pharmacological or UHD dose; test: T3 100 nM and challenged with T3 10cH (UHD); positive control: T3 100 nM, treated with unsuccussed ethanol. The apoptotic index and the area of explants of test and control groups at the first and final day of the experiment were compared by t-test.

Results

There was no difference in tail tip area between test and control groups, but a significantly higher (p < 0.01) index of apoptosis in explants of the test group.

Conclusion

This data suggest that T3 10cH modifies the effect of T3 at pharmacological dose, opening new perspectives for further studies and investigation of the dose–effect curve.

Keywords: Ultra High Dilution; Triiodothyronine; Apoptosis; Rana catesbeiana; Organ culture; Metamorphosis; Endo-isopathy; Homeopathy

Influence of Potassium Dichromate on Tracheal Secretions in Critically Ill Patients*

/

Influence of Potassium Dichromate on Tracheal Secretions in Critically Ill Patients*Michael Frass, MD; Christoph Dielacher, RN; Manfred Linkesch, MD; Christian Endler, PhD; Ilse Muchitsch, PhD; Ernst Schuster, PhD; and Alan Kaye, MD Background: Stringy, tenacious tracheal secretions may prevent extubation in patients weaned from the respirator. This prospective, randomized, double-blind, placebo-controlled study with parallel assignment was performed to assess the influence of sublingually administered potassium dichromate C30 on the amount of tenacious, stringy tracheal secretions in critically ill patients with a history of tobacco use and COPD. Methods: In this study, 50 patients breathing spontaneously with continuous positive airway pressure were receiving either potassium dichromate C30 globules (group 1) [Deutsche Ho- mo ̈opathie-Union, Pharmaceutical Company; Karlsruhe, Germany] or placebo (group 2). Five globules were administered twice daily at intervals of 12 h. The amount of tracheal secretions on day 2 after the start of the study as well as the time for successful extubation and length of stay in the ICU were recorded. Results: The amount of tracheal secretions was reduced significantly in group 1 (p < 0.0001). Extubation could be performed significantly earlier in group 1 (p < 0.0001). Similarly, length of stay was significantly shorter in group 1 (4.20 􏰀 1.61 days vs 7.68 􏰀 3.60 days, p < 0.0001 [mean 􏰀 SD]). Conclusion: These data suggest that potentized (diluted and vigorously shaken) potassium dichromate may help to decrease the amount of stringy tracheal secretions in COPD patients. (CHEST 2005; 127:936–941) Key words: COPD; double-blind, randomized, placebo-controlled study; extubation; homeopathy; tracheal secretions Abbreviations: APACHE 􏰁 acute physiology and chronic health evaluation; BMI 􏰁 body mass index; CPAP 􏰁 con- tinuous positive airway pressure; Fio2 􏰁 fraction of inspired oxygen

Research Study on the remedy "Plumbum metallicum"

/

Homeopathic pathogenetic trial of Plumbum metallicum: the complete 2000 trial with a synthesis of the original 1828 trial

ABSTRACT Background: in a previous paper we reported the statistical analysis and other distribution data of a homeopathic pathogenetic trial (HPT) of Plumbum metallicum 30cH carried out by our group. However, at that time we did not report the resulting pure materia medica, i.e., the totality of symptoms elicited by the tested medicine on healthy volunteers. Aim: to communicate to the homeopathic community the full record of symptoms collected in our HPT of Plb. Methods: methods to collect and select symptoms have been reported in the previous paper. In synthesis were excluded all previous common symptoms of volunteers, even with slight differences, and selected only those that were really unknown, never seen, unusual or very strange for the prover. In this paper special emphasis was given to new symptoms as well as unusual or repeated dreams, while in the previous paper special emphasis was given to repeated and crossed symptoms. Results: symptoms are reported in their chronological order of appearance in each volunteer. 37 new symptoms were found, useful to update Homeopathic Repertories. It is also included a synthesis of the original HPT of Plb carried out in 1828 in order to make available the full experimental materia medica currently existing. Conclusions: the new HPT, besides widening the pathogenetic picture of Plb (skin and mucosae symptoms), also allowed us to give new and deeper meanings to some of the symptoms reported in the original trial, such as Anxiety, Activity, Depression, Slowness, Gastro-oesophageal problems, Colitis. The dreams complete the remedy image, mainly in work, religion and sexual themes. Up to the present time there is no peer-reviewed publication devoted to HPTs. For this reason, researchers are compelled to publish HPTs as private editions. This results in poor control of the quality of publications and a lack of standards on how to present the results of HPTs. Key words: Homeopathic pathogenetic trials, Plumbum metallicum, retrial, clinical indications.